Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis
about
New developments in peritoneal fibroblast biology: implications for inflammation and fibrosis in peritoneal dialysisThe Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal MetastasisThe role of the peritoneum in the pathogenesis of endometriosisMesenchymal Conversion of Mesothelial Cells Is a Key Event in the Pathophysiology of the Peritoneum during Peritoneal DialysisTargeting cannabinoid signaling for peritoneal dialysis-induced oxidative stress and fibrosis.Peritoneal resting with heparinized lavage reverses peritoneal type I membrane failure. A comparative study of the resting effects on normal membranes.A pathogenetic role for endothelin-1 in peritoneal dialysis-associated fibrosisEncapsulating peritoneal sclerosis-a rare but devastating peritoneal disease.Transition of mesothelial cell to fibroblast in peritoneal dialysis: EMT, stem cell or bystander?Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damageEfficacy and mechanism of tanshinone IIA liquid nanoparticles in preventing experimental postoperative peritoneal adhesions in vivo and in vitro.Rapamycin Protects from Type-I Peritoneal Membrane Failure Inhibiting the Angiogenesis, Lymphangiogenesis, and Endo-MT.miR-9-5p suppresses pro-fibrogenic transformation of fibroblasts and prevents organ fibrosis by targeting NOX4 and TGFBR2Cyclooxygenase-2 mediates dialysate-induced alterations of the peritoneal membraneChanges in expression of four molecular marker proteins and one microRNA in mesothelial cells of the peritoneal dialysate effluent fluid of peritoneal dialysis patientsBeta-catenin participates in dialysate-induced peritoneal fibrosis via enhanced peritoneal cell epithelial-to-mesenchymal transition.Genomic reprograming analysis of the Mesothelial to Mesenchymal Transition identifies biomarkers in peritoneal dialysis patientsThe Role of Tyrosine Kinase Receptors in Peritoneal FibrosisThy-1+/- fibroblast subsets in the human peritoneum.Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis.Cannabinoid receptors as therapeutic targets for dialysis-induced peritoneal fibrosis.Immune-Regulatory Molecule CD69 Controls Peritoneal Fibrosis.Mesothelial-to-mesenchymal transition in the pathogenesis of post-surgical peritoneal adhesions.Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90Peritoneal Dialysis Fluid and Some of Its Components Potentiate Fibrocyte Differentiation.Effects of atorvastatin on development of peritoneal fibrosis in rats on peritoneal dialysis.PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage.Human peritoneal fibroblasts are a potent source of neutrophil-targeting cytokines: a key role of IL-1beta stimulation.Regeneration of peritoneal mesothelial cells after placement of hyaluronate carboxymethyl-cellulose (Seprafilm®).Angiogenic capacity of human omental stem cells.Activation of nuclear factor of activated T cells 5 in the peritoneal membrane of uremic patients.Tissue remodeling and nonendometrium-like menstrual cycling are hallmarks of peritoneal endometriosis lesions.Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness.Co-micellized Pluronic mixture with thermo-sensitivity and residence stability as an injectable tissue adhesion barrier hydrogel.RhoA/Rho-kinase triggers epithelial-mesenchymal transition in mesothelial cells and contributes to the pathogenesis of dialysis-related peritoneal fibrosis.Human umbilical cord mesenchymal stem cells facilitate the up-regulation of miR-153-3p, whereby attenuating MGO-induced peritoneal fibrosis in rats.
P2860
Q26780145-BD1577C1-B874-4123-8902-DEC221721108Q26783022-F98F5C96-207A-4229-BBBF-46E4497D0E82Q26998559-5165F45D-1E1F-4329-A900-0A702C54DA0FQ28390104-1B2FB261-79EA-42B0-B760-8FC0C22A3B56Q33655394-2BF2C8A5-4780-4A83-BB0F-30FC9122BA76Q34725067-EA148AEB-A171-467D-8072-7B957B7CCA70Q34787745-D643CF6A-A24E-4E9B-9B3D-A017032FAFB1Q34816520-EBF8018F-CEE4-4C03-8DB5-DC43D3FF9605Q35106053-EEB0DAC3-2A67-44DA-934B-13C4CB7CD598Q35210203-88798B0E-DE07-42E5-8929-EFB90919BED5Q35654651-221E355F-6E88-4351-8BE7-254D86759BA4Q36356537-602BECC7-03A8-44E0-98DE-958026DD90FBQ36615791-A6D10EFD-F4C2-4F09-AD8B-BF0DA3A16D8FQ37123283-77601FFF-327A-4167-8734-A6D7CE1DAEC9Q37288876-3B9B85A8-2513-4322-B25F-D457440EF218Q37625607-52205105-7C35-434A-BAEB-E4CC2600A042Q37715008-A8AC5D39-2B68-4FD1-B3F5-79161B71C47FQ38602815-227D4592-51B8-4909-8751-8B1E859959C0Q38671512-85461E79-2AD8-468F-BF55-8D0D5E26F2B1Q39082233-E1F5F975-37ED-432D-8DFA-7FF7F1112620Q39215034-FFFBD2FB-3D0F-4388-8ED2-32C4026680A1Q39789853-EF89296A-4203-4CE3-851A-5CCFD4BFBA79Q39856481-D54243D0-E777-4580-A86D-495F370F04A4Q41630154-8D966655-90EE-463E-AE6D-052485B069DBQ42430642-1AB93068-FD18-42CC-8286-435792F33AE6Q42878425-73AF65A5-9A24-46BB-9B66-8A9DA5CF1E7AQ43040958-C52D934F-1067-4882-A174-800EBFB30C2DQ45711190-96FF06CC-2A11-44DA-AEAA-CCF5E73B99AFQ50899496-96B2A61A-E53E-4029-A8EF-8CDD366D7209Q51304565-DD85C165-CE30-45A6-809E-DC489BB2BA87Q52868204-FC972756-A866-4345-B19D-C97D6AF3C710Q52887281-18B955A8-C7CA-4063-969B-390E466D383DQ53279967-E2AEFCFF-C1D1-4DB7-A7F7-8DEFE1564325Q54448910-4D1D2C9E-8F5E-4B80-9AE0-80709E4C282FQ54981633-804B8615-D3F5-42A4-8670-D273D716D2ACQ55492130-DD211894-85C7-4C48-B80B-82C99EB52CE0
P2860
Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis
description
scientific article published on 29 January 2004
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2004
@uk
name
Immunohistochemical characteri ...... neal dialysis-induced fibrosis
@en
Immunohistochemical characteri ...... neal dialysis-induced fibrosis
@nl
type
label
Immunohistochemical characteri ...... neal dialysis-induced fibrosis
@en
Immunohistochemical characteri ...... neal dialysis-induced fibrosis
@nl
prefLabel
Immunohistochemical characteri ...... neal dialysis-induced fibrosis
@en
Immunohistochemical characteri ...... neal dialysis-induced fibrosis
@nl
P2093
P1433
P1476
Immunohistochemical characteri ...... neal dialysis-induced fibrosis
@en
P2093
Abelardo Aguilera
Carlos Gamallo
Gloria del Peso
José A Jiménez-Heffernan
José A Sánchez-Tomero
Luiz S Aroeira
M Auxiliadora Bajo
Marta Ramírez
Rafael Selgas
Vicente Alvarez
P2888
P304
P356
10.1007/S00428-003-0963-3
P577
2004-01-29T00:00:00Z